Patent · US Active

Obesity treatment

US10765716B2 · kind B2 · utility

0Cited by
0References
2Claims
0Family size

Inventors

Key dates

Filing dateAug 8, 2017
Grant dateSep 8, 2020
Priority date
Expiry dateMar 20, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2236/33
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method for treating the onset of obesity, reducing dyslipidemia and improving insulin sensitivity in mammals comprising administering a therapeutically effective amount of dried alcoholic extract of Cordia latifolia orally at a dose of 300 mg/kg of body weight to mammals in need for the reducing body weight and managing diabetic conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.